RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia.

Blood Adv · 2024 · PMC10918494 · PMID 38127276

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendP = .09so close (0.05 < p ≤ 0.1)

Although not significant, the MLC group also showed a trend toward shorter overall survival (OS) (median, 29 vs 64 months, respectively; 95% CI, 21.2-84.9; log-rank P = .09).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.